EUVIMEDEUVIMED entdecken
Übersichtsarbeit

The recent progress of γδ T cells and its targeted therapies in rheumatoid arthritis

Xue Feng, Yan Xu iD

International Journal of Rheumatic Diseases · 2024

DOI: 10.1111/1756-185x.15381 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift International Journal of Rheumatic Diseases, 2024. Verfasst von Xue Feng und 1 weiteren Autor:innen. Beteiligte Einrichtung: Department of Bone and Joint Surgery, The First Bethune Hospital of Jilin University, Changchun, China. Hauptthemen laut MEDLINE: Arthritis, Rheumatoid. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 80 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Rheumatoid arthritis (RA) is an autoimmune condition that mostly impacts the joints. During the advanced phases of the disorder, it may be accompanied by other problems. While the precise cause of RA is uncertain, various research has been conducted to gain a better understanding of the immunological processes involved in the development of RA. T cells are acknowledged as significant contributors to the progression of RA because of their roles in cytokine secretion, antigen presentation, and facilitating B cells in the manufacture of antibodies. γδ T cells are a small subset of T cells that have significant functions in the context of infection and diseases linked with tumors. γδ T cells have been the subject of investigation in autoimmune disorders in recent years. This review focused on the involvement of γδ T lymphocytes in the development of RA. In this article, we provide an analysis of the immunological capabilities of γδ T cells, intending to comprehend their significance in RA, which could be pivotal in the creation of innovative clinical treatments.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Arthritis, RheumatoidHumansAnimalsReceptors, Antigen, T-Cell, gamma-deltaAntirheumatic AgentsSignal TransductionMolecular Targeted TherapyT-Lymphocyte SubsetsAutoimmunityT-Lymphocytes

Stichwörter der Autor:innen

T celllymphocyterheumatic diseaserheumatoid arthritisγδ T cells

Substanzen

Receptors, Antigen, T-Cell, gamma-deltaAntirheumatic Agents

Autor:innen und Institutionen

  • Department of Bone and Joint Surgery, The First Bethune Hospital of Jilin University, Changchun, China.

ORCID-Profile: Yan Xu

Zitieren

APA

Feng, X., & Xu, Y. (2024). The recent progress of γδ T cells and its targeted therapies in rheumatoid arthritis. International Journal of Rheumatic Diseases. https://doi.org/10.1111/1756-185x.15381

Vancouver

Feng X, Xu Y. The recent progress of γδ T cells and its targeted therapies in rheumatoid arthritis. International Journal of Rheumatic Diseases. 2024. doi:10.1111/1756-185x.15381

BibTeX
@article{Feng2024,
  author = {Feng, Xue and Xu, Yan},
  title = {The recent progress of γδ T cells and its targeted therapies in rheumatoid arthritis},
  journal = {International Journal of Rheumatic Diseases},
  year = {2024},
  doi = {10.1111/1756-185x.15381}
}
Kostenlos starten →